Quantitation of large, middle and small hepatitis B surface proteins in HBeAg‐positive patients treated with peginterferon alfa‐2a-Reference-Cited by-同舟云学术

Quantitation of large, middle and small hepatitis B surface proteins in HBeAg‐positive patients treated with peginterferon alfa‐2a

Published:2019-12-18 Issue:2 Volume:40 Page:324-332
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Rinker Franziska¹²,Bremer Corinna M.³⁴,Schröder Kathrin³⁴,Wiegand Steffen B.¹,Bremer Birgit¹,Manns Michael P.¹²,Kraft Anke R.¹²^ORCID,Wedemeyer Heiner¹²,Yang Lei⁵,Pavlovic Vedran⁶,Wat Cynthia⁶,Gerlich Wolfram H.³,Glebe Dieter³⁴,Cornberg Markus¹²⁷^ORCID

Affiliation:

1. Department of Gastroenterology, Hepatology and Endocrinology Hannover Medical School Hannover Germany

2. German Center for Infection Research (DZIF) Hannover‐Braunschweig Germany

3. Institute of Medical Virology Justus Liebig University Giessen National Reference Center for Hepatitis B and D viruses Giessen Germany

4. German Center for Infection Research (DZIF) Giessen‐Marburg‐Langen Germany

5. Roche (China) Holding Ltd Product Development–Biometrics/Biostatistics Shanghai China

6. Roche Products Ltd Product Development–Clinical Science Welwyn Garden City UK

7. Centre for Individualized Infection Medicine (CIIM), A Joint Venture of Helmholtz Centre for Infection Research and Hannover Medical School Hannover Germany

Funder

Roche

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14298

Reference28 articles.

1. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

2. AASLD guidelines for treatment of chronic hepatitis B

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection